Skip to main content
Premium Trial:

Request an Annual Quote

Mark Frost, Dennis Gilbert, and Michael Gribskov


Mark Frost is the new CFO of Albany Molecular Research effective Dec. 1, the Albany, NY-based biotech firm said this week. Frost joins Albany Molecular Research from Smith & Nephew Endoscopy, where he served as vice president of finance. Prior to this, he spent 14 years in various positions at General Electric.

Dennis Gilbert has become CSO and vice president for research of Applied Biosystems, as well as vice president of Applera, the company said in an SEC filing last week. He joined Applera in 1994 as a research scientist and was most recently ABI’s vice president for advanced research and technology.

Michael Gribskov has joined the department of biological sciences at Purdue University. He was previously lead scientist in computational biology at the San Diego Supercomputer Center. Gribskov is the current president of the International Society for Computational Biology.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.